11.07.2015 Views

Clinician's Pocket Drug Reference 2008

Clinician's Pocket Drug Reference 2008

Clinician's Pocket Drug Reference 2008

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

144 Mexiletinetid for 7 d or 2 g PO × 1. C. difficile: 500 mg PO or IV q8h for 7–10 d (PO preferred;IV only if pt NPO). Vaginosis: 1 applicatorful intravag bid or 500 mg PObid for 7 d. Acne rosacea/skin: Apply bid. Peds. 30 mg/ kg PO/IV/day dividedq6H, 4 gm day max÷. Amebic dysentery: 35–50 mg/kg/24 h PO in 3 ÷ doses for5–10 d;, Rx 7-10 day for c. diff; ↓ in hepatic impair Caution: [B, M] Avoid EtOHContra: First tri of PRG Disp: Tabs 250, 500 mg; XR tabs 750 mg; caps 375 mg;IV 500 mg/100mL; topical lotion & gel 0.75%; intravag gel 0.75% (5 g/applicator37.5 mg in 70-g tube), cream 1% SE: Disulfiram-like Rxn; dizziness, HA, GIupset, anorexia, urine discoloration Notes: For trichomoniasis, Rx pt’s partner; noaerobic bacteria activity; use in combo w/ serious mixed InfxnsMexiletine (Mexitil) WARNING: Mortality risks noted for flecainide and/orencanite (type 1 anti-arrhythmics). Reserve for use in patients with life-threatening VentricularArrhythmias Uses: *Suppress symptomatic ventricular arrhythmias*; diabeticneuropathy Action: Class IB antiarrhythmic (Table 10) Dose: Adults. 200–300 mg POq8h; 1200 mg/d max. Peds. 2.5–5 mg/kg PO q 8h; w/ food or antacids Caution: [C, +]May worsen severe arrhythmias; interacts w/ hepatic inducers & suppressors (dosagechanges) Contra: Cardiogenic shock or 2nd-/3rd-degree AV block w/o pacemakerDisp: Caps 150, 200, 250 mg SE: Lightheadedness, dizziness, anxiety, incoordination,GI upset, ataxia, hepatic damage, blood dyscrasias Notes: monitor LFTs CBCMiconazole (Monistat, others) Uses: *Candidal Infxns, dermatomycoses(various tinea forms)* Action: Fungicide; alters fungal membrane permeabilityDose: Apply to area bid for 2–4 wk. Intravag: 1 applicatorful or supp hs for3 (4% or 200 mg) or 7 d (2% or 100 mg) Caution: [C, ?] Azole sensitivity Disp:Topical cream 2%; lotion 2%; powder 2%; spray 2%; vag supp 100, 200 mg; vagcream 2%, 4% [OTC] SE: Vag burning, may ↑ warfarin Notes: Antagonistic toamphotericin B in vivoMiconazole/zinc oxide/petrolatum (Vusion) Uses: *Candidaldiaper rash* Action: Combo antifungal Dose: Peds > 4 wks: apply at each diaperchange × 7d Caution: [C, ?] Contra: None Disp: Miconazole/zinc oxide/petrolatumoint 0.25%/81.35%/15% SE: None Notes: Keep diaper dryMidazolam [C-IV] Uses: *Preop sedation, conscious sedation for shortprocedures & mechanically ventilated pts, induction of general anesthesia* Action:Short-acting benzodiazepine Dose: Adults. 1–5 mg IV or IM; titrate to effect.Peds. Preop: > 6 mo 0.25–1 mg/kg PO, 20 mg max. Conscious sedation: 0.08mg/kg × 1. > 6 mo 0.1–0.15 mg/kg IM × 1 max 10 mg. General anesthesia: 0.025–0.1 mg/kg IV q2min for 1–3 doses PRN to induce anesthesia (↓ in elderly, w/ narcoticsor CNS depressants) Caution: [D, +/–] w/CYP3A4 substrate (Table 11),multiple drug interactions Contra: NAG; w/amprenavir, nelfinavir, ritonavir Disp:Inj 1, 5 mg/mL; syrup 2 mg/mL SE: Resp depression; ↓ BP w/ conscious sedation,N Notes: Reversal w/ flumazenil; monitor for resp depressionMifepristone [RU 486] (Mifeprex) WARNING: Pt counseling & informationrequired; associated w/ fatal infections & bleeding Uses: *Terminate

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!